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Abstract
The cytoarchitectonically-uniform dorsal lateral geniculate nucleus (dLGN) can be biochemically and anatomically subdivided in
wild-type mice: The nucleus dorsolateral shell region contains the majority of cells positive for the calcium-binding protein calbin-
din-D28k, and receives the strongest concentration of inputs from the superior colliculus. This subdivision remains normal in mice
lacking the b2 subunit of the nicotinic acetylcholine receptor. Although in these animals the dLGN contains fewer calbindin-positive
cells, those cells are predominantly situated in the dorsolateral portion of the nucleus, and this region remains preferentially targeted
by the colliculogeniculate projection.
 2004 Elsevier Ltd. All rights reserved.
Keywords: Mouse; Calbindin; Colliculogeniculate; Development; Thalamus1. Introduction
In carnivores and primates, a major feature of the
dorsal lateral geniculate nucleus (dLGN) is its division
into biochemically-, anatomically- and functionally dis-
tinct subregions, a division which often, though not al-
ways, occurs on a laminar template (e.g. Casagrande,
1994; Sherman, 1985). Although the mouse dLGN is
not cytoarchitectonically laminated, it too is subdivided:
Inputs from the two eyes occupy separate regions of the
nucleus (Godement, Salaun, & Imbert, 1984). This0042-6989/$ - see front matter  2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.visres.2004.09.003
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c-aminobutyric acid; nAChR, nicotinic acetylcholine receptor; LP,
lateral posterior nucleus; NGS, normal goat serum; PBS, phosphate-
buﬀered saline; SC, superior colliculus; SEM, standard error of the
mean; vLGN, ventral lateral geniculate nucleus; WT, wild-type
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also processes other aspects of the visual world in paral-
lel, in other hidden laminae (Reese, 1988). Indeed,
numerous pieces of anatomical evidence suggest that
such a hidden lamina exists in the dorsolateral region
of the dLGN in the mouses close rodent relative, the
rat (Reese, 1988).
Is the dorsolateral region of the mouse dLGN also
diﬀerent from the remainder of the nucleus? We investi-
gate this question using two techniques that have dem-
onstrated geniculate subdivision in other mammalian
species. Immunocytochemical labelling of calcium-bind-
ing proteins has revealed distinct diﬀerences between
separate laminae in the primate dLGN: Only neurons
in the small-celled koniocellular layers contain calbin-
din-D28k, while parvalbumin-containing neurons are
found in all other geniculate laminae (Diamond, Fitzpa-
trick, & Schmechel, 1993; Goodchild & Martin, 1998;
Johnson & Casagrande, 1995; Jones & Hendry, 1989).
Similar biochemical distinctions in the carnivore,
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1991). Subdivision by another feature is more conserved
across mammalian species: Neuroanatomical tracing
has revealed that the projection to the dLGN from the
superior colliculus (SC) always terminates predomi-
nantly in small-celled regions of the nucleus, including
the primate koniocellular layers and the C laminae in
carnivores (Harting, Huerta, Hashikawa, & van Lie-
shout, 1991; Reese, 1984). Employing immunohisto-
chemical labelling of calcium-binding proteins and
neuroanatomical tracing of the colliculogeniculate pro-
jection in the present study should reveal whether mouse
dLGN is also subdivided according to these biochemical
and anatomical features.
We also study biochemical and anatomical subdivi-
sion of the dLGN in mice lacking the b2 subunit of
the nicotinic acetylcholine receptor (nAChR). The
organisation of the dLGN in these animals is already
known to be profoundly abnormal. In addition to deﬁ-
cits in ﬁne retinotopy (Grubb, Rossi, Changeux, &
Thompson, 2003) and anomalous organisation accord-
ing to On–Oﬀ receptive ﬁeld type (Grubb et al., 2003),
ocular organisation is severely disturbed in the b2/
geniculate. Ocular segregation is normal, with individual
geniculate cells receiving inputs from only one eye
(Muir-Robinson, Hwang, & Feller, 2002; Grubb et al.,
2003), but ocular lamination does not occur; instead,
ipsilateral inputs to the b 2/ dLGN form a series of
small isolated islands surrounded by contralaterally-
innervated tissue (Rossi et al., 2001; Muir-Robinson
et al., 2002). Here we investigate whether these deﬁcits
in functional organisation, believed to be caused by
abnormal patterns of spontaneous activity in the devel-
oping postnatal b2/ retina (McLaughlin, Torborg,
Feller, & OLeary, 2003), are accompanied by additional
abnormalities in hidden biochemical or colliculogenicu-
late subdivision of the mouse dLGN.2. Methods
2.1. Animals
Wild-type animals were adult (>3 months of age) pig-
mented C57Bl/6J mice of either sex weighing 18–33 g
(Harlan Olac, Oxon, UK). Mice lacking the b2 sub-
unit of the nicotinic acetylcholine receptor (b2/) were
generated at the Institut Pasteur in Paris, France (Picci-
otto et al., 1995), and were backcrossed for at least
12 generations onto the C57Bl/6J strain. Adult male
b2/ mice weighing 29–36 g were used. Mice were
housed in single-sex groups with freely available dry
food and water under a 12:12 h cycle of light and dark.
All procedures were conducted under the auspices of
UK Home Oﬃce Project and Personal licenses held
by the authors.2.2. Immunocytochemistry
Mice were overdosed with an intraperitoneal injec-
tion of 0.3–0.5 ml pentobarbitone sodium (Sagatal;
60 mg/ml;Rhoˆne Me´rieux Ltd., Essex, UK), then per-
fused transcardially with phosphate buﬀered saline
(PBS; Sigma) followed by 4% paraformaldehyde (TAAB
Laboratories, Berks, UK) in 0.1 M phosphate buﬀer.
After post-ﬁxing of the head for >1 week in 4% parafor-
maldehyde, brains were removed, sunk in 30% sucrose
for cryoprotection, and sectioned coronally at 30–
40 lm on a freezing microtome.
Throughout the immunocytochemical process, free-
ﬂoating sections were agitated gently. Sections were ini-
tially transferred into phosphate-buﬀered saline (PBS)
for 30 min, before incubation for 1 h at room tempera-
ture in blocking buﬀer consisting of 1% bovine serum
albumin (Vector Laboratories, Peterborough, UK), 5%
normal goat serum (NGS; Vector Laboratories, Peter-
borough, UK) and 0.3% Triton X-100 (Sigma) in PBS.
This was followed by overnight incubation at 4 C in
primary antibody solution, either 1:3000 rabbit anti-cal-
bindin D-28k (Chemicon International, Harrow, UK),
or 1:5000 rabbit anti-parvalbumin (a gift from Vivien
Lane, University Laboratory of Physiology, Oxford,
UK), in PBS plus 1% NGS and 0.3% Triton X-100. In
1 wild-type mouse, every section in the left hemisphere
was stained for parvalbumin and every section in the
right hemisphere was stained for calbindin; in 2 wild-
type mice, alternate sections in both hemispheres were
stained for calbindin and parvalbumin; in 5 wild-type
and 8 b2/mice, all sections were stained for calbindin
(4 wild-type bilaterally); and in 15 wild-type and 5
b2/ mice (those that had received injections of [3 H]
proline into the superior colliculus, see below), a 1:3 ser-
ies of sections through the extent of the dLGN in one
hemisphere was calbindin-stained. Control sections in
each animal were incubated overnight in PBS plus 1%
NGS and 0.3% Triton X-100, but minus any primary
antibody. These sections never contained any labelled
tissue.
After removal of the primary antibody solution and
3 · 30 min washes in PBS plus 0.3% Triton X-100, sec-
tions were incubated for 2 h at room temperature in a
secondary antibody solution consisting of 1:200/500
biotinylated goat anti-rabbit IgG (Vector Laboratories,
Peterborough, UK), in PBS plus 1% NGS and 0.3% Tri-
ton X-100. This was followed by another 3 · 30 min
washes in PBS plus 0.3% Triton X-100, and incubation
in an avidin–biotin complex solution (VectaStain Elite
ABC Kit, Vector Laboratories, Peterborough, UK) for
2 h at room temperature. Then, after 5 · 30 min PBS
washes, sections were reacted with diaminobenzidine
(SigmaFast DAB tablets, Sigma; 0.06% nickel ammo-
nium sulphate was added to intensify reaction product).
Following a ﬁnal wash in PBS, sections were mounted
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through graded alcohols, cleared in xylene, and cover-
slipped with DePeX (BDH, Dorset, UK).
All stained sections including the dLGN were in-
spected using a light microscope under bright ﬁeld illu-
mination. For each of these sections, a camera lucida
was used to draw the outline of the dorsolateral thal-
amus (marked in most part by the optic tract (OT)),
the outline of the dLGN, and any densely-labelled cell
bodies within the dLGNs borders. A line parallel to
and 100 lm from the ventromedial border of the optic
tract was then added to each drawing, enabling a count
of stained cells lying within and outside the dLGNs
dorsolateral shell region.
2.3. Neuroanatomical tracing
Preparation of [3H] proline: To obtain a 100 lCi/ll
concentration of [3H] proline for injection, and to enable
injection site visualisation, a 1 mCi/ml stock solution of
[3H] proline (Amersham International, Bucks., UK) was
freeze dried and combined with the appropriate volume
of 0.9% sterile saline plus 0.04% Fast Green FCF.
Surgical procedures: Mice were ﬁrst anaesthetised
with an intraperitoneal injection of 25% fentanyl and
ﬂuanisone (HypnormTM; Janssen Animal Health, Bucks,
UK) and 25% midazolam (Hypnovel; Roche Products
Ltd, Herts, UK) in Water for Injections (Norbrook
Laboratories Ltd., Co. Down, UK), administered at
2.7 ll/g. Surgical anaesthesia, deﬁned as a complete lack
of paw pinch reﬂex, was maintained throughout tracer
injection procedures by subsequent applications of this
induction dose. To prevent the accumulation of bron-
chial secretions, 5 ll atropine sulphate (600 lg/ml,
Animalcare Ltd., Yorks; UK) was also given subcutane-
ously. Once the animals head had been steadied in a
stereotaxic frame, an incision was made over the pre-
sumptive injection site and connective tissue was cleared
to reveal the skull. For injections into the far caudome-
dial superior colliculus (SC), a craniotomy  2 mm in
diameter was made caudal to the lambda suture, with
care taken not to damage large underlying blood vessels.
For injections elsewhere in the SC, a larger craniotomy
was made lateral of the midline and approximately level
with the lambda suture. Cortical tissue was then aspi-
rated to allow visualisation of the (central–lateral) SC.
[3H] proline solution was injected under air pressure
using pipettes pulled from borosilicate glass tubing (out-
er diameter 0.8 mm, inner diameter 0.12 mm; Plowden
and Thompson Ltd., Stourbridge, UK). Injections were
made at multiple locations over the visible extent of
the SC, and were aimed at superﬁcial layers just below
the pial surface. Typically, a total of 50–200 nl of tracer
was injected unilaterally in 2–8 locations. After the com-
pletion of tracer injections, craniotomies were ﬁlled with
absorbable haemostat material (Gelfoam, AmershamInternational, Bucks., UK) and/or bone wax (Ethicon,
Edinburgh, UK). Where sections of skull had been re-
moved during larger craniotomies, these were replaced
and sealed with bone wax. Incisions were then securely
stitched and treated with local anaesthetic cream
(EMLA; Astra Pharmaceuticals Ltd., Herts, UK). Ani-
mals were left to recover in individual cages on soft
bedding, with warmth provided by a closely positioned
desk lamp. Occasional  0.15 ml subcutaneous injec-
tions of a 4% glucose, 0.18% saline solution (Aqupharm,
Animalcare Ltd., York, UK) were given to aid recovery.
Once post-operative mice were awake and spontane-
ously moving, they were placed in individual cages with
freely available food and water and returned to the ani-
mal house.
Histological processing: 24–48 h after injections of
[3H] proline, mice were overdosed with 0.3–0.5 ml Saga-
tal and perfused transcardially with PBS followed by 4%
paraformaldehyde in 0.1 M phosphate buﬀer. After a
post-ﬁxation period of >1 week in 4% paraformalde-
hyde in 0.1 M phosphate buﬀer, brains were removed,
sunk in 30% sucrose and sectioned coronally at 30–40
lm on a freezing microtome. A 1:3 series of sections
was stained for calbindin D-28k (see above) when it in-
cluded the dLGN, and was Nissl stained when it did not.
All other sections were mounted from distilled water
onto gelatinised slides, and processed for autoradiogra-
phy. These sections were ﬁrst brought through graded
alcohols to be cleared in xylene for 20 min, then re-
turned through graded alcohols and oven dried. Under
safelight illumination, slides were dipped in autoradio-
graphic emulsion (EM-1, Amersham International,
Bucks., UK) at 43 C, and air dried. They were then
incubated in light-tight containers for 4 weeks at 4 C.
Again under safelight illumination, these slides were
developed (D19, Kodak) and ﬁxed (Hypam Rapid
Fixer, Ilford, Cheshire, UK), before (in normal light)
being brought through graded alcohols, cleared once
more in xylene and coverslipped with DePeX.
Quantitative analysis: After qualitative observation
under dark ﬁeld illumination, photographs were taken
of all sections from brains injected with [3H] proline that
contained dense, above background anterograde label
within the dLGN. Photographic negatives of the dark-
ﬁeld illuminated sections were then scanned and
converted to 600 dpi resolution TIF images (Nikon
Coolscan IV). Quantitative analysis of these images
was undertaken using the ImageJ programme (http://
rsb.info.nih.gov/ij/). Measurements of mean grey value
(MGV; i.e., image lightness) and area (area) were
obtained for three regions in each section: a 100 lm
square region in non-visual thalamus (background),
the dLGN as a whole (dLGN), and the shell region
occupying the strip of tissue within 100 lm of the
OTs ventromedial border (shell). These measures were
used in two ways. The ﬁrst, %label_shell, is a measure
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located in the shell region. The second, relative density,
indicates the relative intensity of the labelling within the
shell. It should be noted that because of the very non-
linear relation between [3H] and MGV in dark-ﬁeld illu-
mination both measures will underestimate the relative
strength of the projection to the shell. The %label_shell
measure was calculated for each section, as follows:
%label shell
¼ 100 areashell  ðMGVshell MGVbackgroundÞ
areadLGN  ðMGVdLGN MGVbackgroundÞ :
ð1Þ
This measure is calculated within each section, so
should be less susceptible to variation between sections
that might be caused by non-speciﬁc tissue, histological
or photographic inconsistencies. The measure was also
intended to be a close homologue of the calbindin+ shell
% measure (see Section 3)—it describes the proportion
of above-background image intensity in the dLGN that
is contained within the dorsolateral shell region—and
should be independent of the overall strength or extent
of anterograde label. A second measure, relative den-
sity, is an extension of the %label_shell measure. It sim-
ply takes a %label_shell value and divides it by the
percentage of dLGN area occupied by the shell region
in a given section:
relative density ¼ %label shell
100 ðareashell=areadLGNÞ : ð2Þ
This measure represents, for each section, the propor-
tion of anterograde [3H] proline label within the dLGNs
dorsolateral shell relative to that regions share of the
nucleus area.2.4. Statistical procedures
All statistical analyses were carried out using para-
metric tests and samples were described using the
mean ± SEM. All samples passed a Kolmogorov–Smir-
nov test for Normality, although sample sizes were
probably too small (<30) for this test to be reliable.
For this reason, non-parametric alternatives were also
employed whenever a parametric test was used. In every
case, these non-parametric tests produced identical re-
sults in terms of signiﬁcance. All comparison tests were
two-tailed, with the level of signiﬁcance set at 0.05.
3. Results
3.1. Biochemical subdivision of the wild-type mouse dLGN
Immunocytochemical labelling for calcium-binding
proteins shows that the unlaminated wild-type mouse
dLGN can be divided into two distinct subregions. Inbrains stained for the presence of calbindin D-28k, the
bulk of the dLGN is devoid of positively labelled cells.
However, many small, densely labelled cells are present
in a narrow strip of tissue on the nucleus dorsolateral
edge, adjacent to the optic tract (Fig. 1(A)). Clear local-
isation of calbindin-positive cells in this dorsolateral
dLGN shell region was observed in all 23 wild-type
mice whose brains were stained for the protein.
Although by no means every calbindin-positive cell in
the dLGN was situated right next to the optic tract, only
the odd scattered calbindin-positive cell was located
in the centre of the nucleus, and positively-labelled cells
close to the dLGNs ventromedial border were extre-
mely rare indeed. As shown in Fig. 1(B), localisation
of calbindin-positive cells to the dorsolateral shell of
the dLGN occurred throughout the nucleus rostrocau-
dal extent. Calbindin-positive cells situated away from
the optic tract were most common ventrolaterally, near
the intrageniculate lamina, and were somewhat more
common in caudal sections. Still, even at the far caudal
pole of the dLGN, calbindin-positive cells in ventrome-
dial portions of the nucleus were very rarely seen. Bio-
chemical subdivision of the mouse dLGN thus appears
to occur through the entire nucleus.
A simple approach was taken to quantify these
observations. The shell of the dLGN was deﬁned as
the dorsolateral portion of the nucleus that lay within
100 lm of the optic tract (Fig. 1(B)). A ﬁxed rather
than a relative distance was chosen because the width
of the region containing calbindin-positive cells did
not appear to vary with the size of the dLGN. Indeed,
if anything, calbindin-positive cells occupied a wider
shell zone at the narrow caudal pole of the nucleus
than at its broad rostral levels. For each section
through the dLGN, the numbers of calbindin-positive
cells within and outside the 100 lm shell region were
counted. Within each animal, a shell % was then cal-
culated as the percentage of positively labelled cells
within the shell. Shell % values ranged from 74% to
92% and were tightly clustered around the mean
± SEM of 83 ± 1% (n = 23; Fig. 1(C)). Summing cells
across all animals gives a very similar result: 4123
(83%) calbindin-positive cells were situated in the
dorsolateral shell region, while only 829 (17%) lay in
the core of the dLGN (Fig. 1(C) inset). The large
majority of calbindin-positive cells in the wild-type
mouse dLGN thus lie within 100 lm of the optic
tract, subdividing the nucleus.
In contrast, immunocytochemical labelling for parv-
albumin in 3 wild-type mice (5 hemispheres) failed to
produce a single positively labelled cell within the
dLGN. This was not due to a failure of the labelling
process—as Fig. 1(D) shows, plenty of parvalbumin-
positive cells were present in the hippocampus above
the dLGN, and in the lateral portion of the ventral geni-
culate body (vLGN).
Fig. 1. Biochemical subdivision of the wild-type mouse dLGN. (A) A coronal section through the wild-type mouse dLGN stained for the calcium-
binding protein calbindin D-28k. Distribution of calbindin+ cells appears to subdivide the nucleus: While the dLGN is largely unlabelled, small,
densely-stained cells, indicated with arrows, are concentrated in the dorsolateral dLGN shell adjacent to the optic tract. Larger, densely-labelled
cells in the intrageniculate lamina, ventral to the dLGN, are marked with an asterisk (*). d, dorsal; v, ventral; l, lateral; m, medial; scalebar, 500 lm.
(B) An example of calbindin+ cell distribution throughout the wild-type mouse dLGN, showing clear biochemical subdivision of the nucleus. Each
drawing shows a single coronal section of the dLGN in the context of the dorsolateral boundary of the thalamus, with each dot representing one
calbindin+ cell (not drawn to scale). Numbers to the left of each drawing indicate relative distance from the rostral pole of the dLGN, expressed as a
percentage of the rostrocaudal extent of the nucleus. Along the rostrocaudal extent of the dLGN, calbindin+ cells are almost exclusively localised in
the dorsolateral shell adjacent to the optic tract. No calbindin+ cells are seen near the dLGNs ventromedial border. The section at 49% illustrates
quantiﬁcation of calbindin+ cell localisation. A line (dotted here) was drawn parallel to and 100 lm in from the optic tract, and dLGN calbindin+
cells within and outside this zone counted. Those outside the zone in this section are ringed. For each animal a shell % was calculated as the
percentage of dLGN calbindin+ cells across all sections that were localised within 100 lm of the optic tract. Scalebar, 500 lm. (C) Distribution of
shell % values across 23 wild-type mice. In all animals, immunocytochemical staining for calbindin revealed a clear biochemical subdivision within
the dLGN: Shell % values are clustered tightly around the mean of 83% (indicated with the arrow). The inset pie chart shows that across all 23
animals, 4123 (83%; dark region) calbindin+ dLGN cells were located within 100 lm of the optic tract, while 829 (17%; light region) lay outside this
zone. (D) A coronal section through the wild-type mouse dLGN stained for the calcium-binding protein parvalbumin. Note positively labelled cells
in the hippocampus (upper left) and ventral LGN (lower left). Despite being clearly visible due to background staining, the dLGN contains no
parvalbumin+ cells. Conventions as in A; scalebar, 500 lm.
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colliculogeniculate projection
If a subregion of the wild-type mouse dLGN, like the
primate koniocellular dLGN, is distinguished by
immunocytochemical labelling for calbindin-D28k, the
same region might also mirror the primate koniocellular
dLGN in being the primary focus of the colliculogenicu-
late projection. Anterograde neuroanatomical tracing
with [3H] proline suggests that this is indeed the case.
All injections of [3H] proline into the wild-type mouseSC produced anterograde label in the dLGN that was
concentrated dorsolaterally, close to the optic tract. A
relatively small injection into the caudomedial pole of
the SC produced highly localised anterograde label in
the far lateral, rostral portion of the ipsilateral dLGNs
shell (Fig. 2(A)). Large proline injections into more ros-
tral SC regions, following aspiration of the overlying
cortex, also produced anterograde label concentrated
in the ipsilateral dLGNs dorsolateral region (Fig. 2(B)
and (C)). Although above-background proline terminal
label was often visible throughout the ipsilateral dLGN,
Fig. 2. [3H] proline tracing of the wild-type mouse colliculogeniculate projection. Dark ﬁeld photomicrographs show coronal sections of the superior
colliculus (SC; 1) or dLGN (2). Injection sites in the SC are characterised by a dense core of darkly labelled cells and an outer halo of white proline
label. Anterograde label in the dLGN, whose borders are marked with a dashed line, is white and particulate. The number within each dLGN
photomicrograph represents the distance from the rostral pole of the dLGN, expressed as a percentage of the rostrocaudal extent of the nucleus.
Numbers beneath each dLGN photomicrograph show the %label_shell and relative density measures calculated for that section (see Section 2). IC,
inferior colliculus; SC, superior colliculus; LP, lateral posterior nucleus; vLGN, ventral geniculate nucleus; rd, relative density; scalebars, 500 lm. (A)
Following an injection of proline into the extreme caudomedial SC (1), anterograde label is very precisely localised to the rostrolateral dLGN, and is
most concentrated dorsally adjacent to the optic tract (2). (B) A large proline injection into the central-lateral portion of the SC (1) produces more
widespread anterograde label in the posterior dLGN (2). This label is spread over a considerable extent of the nucleus ventrolateral–dorsomedial
axis, but is clearly localised in the orthogonal axis, being most concentrated dorsolaterally. Note, as in C, the dense label in LP medial to the dLGN,
and in the lateral portion of the vLGN ventral to the dLGN. (C) A second large proline injection into the central-lateral SC (1) produces dLGN label
that is strongest towards the caudal pole of the nucleus (2). Again, this label is concentrated most densely in the dorsolateral shell of the dLGN.
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dial border. Furthermore, in all nine wild-type animals
in which SC injections were successful in producing
dense anterograde label in the dLGN, this labelling
was always strongest dorsolaterally, adjacent to the op-
tic tract. Anterograde tracing with [3H] proline thereforeoﬀers evidence that the wild-type mouse colliculogenicu-
late projection targets a restricted subregion of the
dLGN.
The wild-type mouse colliculogeniculate projection
shows topographic ordering. As noted above, an injec-
tion into the caudomedial superﬁcial SC produced
Fig. 3. Quantitative evaluation of the wild-type mouse colliculogeniculate projection. (A) Histogram of mean %label_shell values for 9 wild-type
mice. Values, approximating the percentage of anterograde proline label contained within the dLGNs dorsolateral shell (see Methods), range from
31% to 53%. The arrow marks the mean at 41%. (B) Histogram of mean relative density values for 9 wild-type mice. Values, representing the
proportion of label within the dLGNs dorsolateral shell relative to that regions share of the nucleus area (see Section 2), are all above unity.
Anterograde proline label is thus most concentrated in the dLGN shell in all 9 cases. The arrow marks the mean at 1.37.
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these sites contain representations of the temporal vis-
ual ﬁeld (Wagner, McCaﬀery, & Drager, 2000). More
common were large injection sites concentrated in lat-
eral portions of the superﬁcial SC, which produced
anterograde label in caudal regions of the dLGN shell
(Fig. 2(B) and (C)). Both these sites contain represen-
tations of the ventronasal visual ﬁeld (Wagner et al.,
2000).
With the intention of putting the above qualitative
observations of proline labelling in the wild-type dLGN
on a ﬁrmer footing, images of all sections containing
dense dLGN label were analysed quantitatively. The
ﬁrst attempt at quantifying the pattern of anterograde
proline label took the form of the %label_shell statistic,
which was intended to represent, like the calbindin shell
% measure described above, the proportion of radioac-
tive proline label lying within the dorsolateral shell of
the dLGN (see Section 2). The distribution of mean %la-
bel_shell values for all 9 wild-type mice with dense
dLGN label is shown in Fig. 3(A). Values range from
31% to 53%, with the mean ± SEM at 41 ± 2%. These
values are much lower than the calbindin shell % values
in Fig. 1; in part, this must be a reﬂection of the fact that
the collicular projection is strongest in the dLGN shell,
but not completely restricted to that region. Inspection
of the images and % values in Fig. 2 also suggests, how-
ever, that the measure might not precisely reﬂect the
proportion of dLGN label contained in the shell region.
The second section in Fig. 2A2, for example, has almost
all its label very close to the optic tract, but receives a
%label_shell value of only 47%. Thus, although the %la-
bel_shell measure may reﬂect relative diﬀerences in the
proportion of shell label across diﬀerent sections, in
any given single section it might not accurately represent
the absolute proportion of [3H] proline transported to
the shell. Image mean grey values following dark-ﬁeld
illumination (see Section 2, Eq. (1)) do not representan accurate, linear measure of the total amount of pro-
line label concentrated in a particular portion of tissue.
Despite these possible drawbacks, a second measure,
relative density (Section 2, Eq. (2)), shows quantita-
tively that the mouse colliculogeniculate projection pre-
dominantly targets the dorsolateral shell region of the
dLGN. In a section with uniform label across the
dLGN, this ratio should be one. When label is concen-
trated in the shell region, it should be greater than
one. In such cases the shell contains more anterograde
label than its area would predict. Fig. 3(B) shows that
mean shell ratio values in all nine analysed mice were
above one, with the sample mean ± SEM at
1.37 ± 0.05. So, although not quite as striking as the
qualitative evidence (see Fig. 2), this quantitative analy-
sis does conﬁrm that the projection from the SC to the
dLGN in the wild-type mouse predominantly targets
the latters dorsolateral shell region.
3.3. Biochemical and anatomical subdivision of the dLGN
in b2/ mice
Inspection of a single calbindin-labelled section from
the b2/ dLGN might lead one to infer that biochem-
ical subdivision of the nucleus is disrupted in these mu-
tant animals. While calbindin-positive neurons in the
b2/ dLGN, like their wild-type counterparts, were
small and densely-labelled (Fig. 4(A)), they were drasti-
cally reduced in number compared to calbindin-contain-
ing cells in normal mice. Each b2/ dLGN section
contained a mean ± SEM of only 1.7 ± 0.2 calbindin-
positive neurons, a mean which was highly signiﬁcantly
diﬀerent from the corresponding wild-type ﬁgure
(11.9 ± 1.1 cells per section; t-test with Welch correction,
p < 0.0001; Fig. 4(B)). However, assessing the localisa-
tion of calbindin-containing neurons across many sec-
tions of the b2/ dLGN (Fig. 4(C)) revealed that, in
spite of their low incidence, these neurons remained
Fig. 4. Calbindin-positive cells are fewer but correctly localised in the b2/ dLGN. (A) A coronal section of the b2/ dLGN stained for calbindin
D-28k. Although the nucleus, marked by the dotted line, is largely devoid of labelled cells, one densely labelled cell is marked by the arrow. Dark
background staining is also visible dorsolaterally, adjacent to the optic tract. The intrageniculate lamina, as in wild-type sections (Fig. 1(A)) contains
larger, densely labelled cells, marked with an asterisk (*). d, dorsal; v, ventral; m, medial; l, lateral; scalebar, 250 lm. (B) The b2/ dLGN contains
far fewer calbindin-positive cells per section than the wild-type dLGN (wild-type mean ± SEM, 12 ± 1; b2/, 2 ± 1; t-test with Welch correction,
p < 0.0001). The inset bar plot shows means for the two groups. Error bars show SEM. (C) A series of drawings showing calbindin-positive cell
locations throughout the rostrocaudal extent of one b2/ dLGN. Each dot (not to scale) marks the location of one labelled cell. Numbers to the left
of each drawing show the rostrocaudal level of each section, expressed as a percentage of the rostrocaudal extent of the dLGN from its rostral pole.
Conventions as in A; scalebar, 500 lm. (D) Calbindin-positive cells are similarly situated within the b2/ dLGN. Although there is a trend towards
a higher percentage of labelled cells in the dorsolateral shell of the dLGN in wild-type mice, calbindin-positive cells are also predominantly located in
this region in b2/ mice. The diﬀerence between the two samples is not signiﬁcant (wild-type mean ± SEM, 83 ± 1%; b2/, 77 ± 4%; t-test with
Welch correction, p = 0.1). The inset bar plot shows means for the two groups. Error bars show SEM. WT, wild-type.
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b2/ mice. Over 13 b2/ mice and 23 wild-type
mice, shell % values were not signiﬁcantly diﬀerent
(wild-type mean ± SEM: 83 ± 1%; b2/: 77 ± 4%;
t-test with Welch correction, p = 0.1; Fig. 4(D)). In
addition, total proportions of shell-localised calbindin-
positive cells across all animals did not diﬀer signiﬁ-
cantly between the two groups (wild-type: 4123/
4952 = 83%; b2/: 229/289 = 79%; v2 test, p = 0.09).
Biochemical subdivision of the b2/ dLGN is
therefore normal, despite a depleted population of
calbindin-containing neurons.
The colliculogeniculate projection is also entirely nor-
mal in b2/ mice. Large injections of [3H] proline into
the SC following aspiration of overlying cortex pro-
duced anterograde label in the dLGN that was strongest
adjacent to the optic tract (Fig. 5(A) and (B)). Over 9
wild-type and 5 b2/ mice, no diﬀerences were found
between either measure of this localisation (%label_
shell:wild-type mean ± SEM, 41 ± 2%; b2/,
43 ± 3%; t-test, p = 0.64; Fig. 5(C); relative den-sity:wild-type mean ± SEM, 1.37 ± 0.05; b2/,
1.55 ± 0.15; t-test with Welch correction, p = 0.3; Fig.
5(D)). The gross topography of the colliculogeniculate
projection also appeared normal in b2/ mice. Injec-
tions concentrated in the lateral SC produced label in
the caudomedial dLGN, while injections covering a
large mediolateral extent of the SC produced label over
a large portion of the dLGNs mediolateral axis (see
above; Wagner et al., 2000). Shell-core lamination of
the dLGN, unlike ocular lamination in the nucleus
(Muir-Robinson et al., 2002; Rossi et al., 2001), is thus
largely unaﬀected by the b2/ mutation.4. Discussion
Our results show that the wild-type mouse dLGN can
be spatially subdivided according to the biochemistry of
its constituent neurons and the strength of its input from
the SC. In particular, the dorsolateral shell of the nu-
cleus, adjacent to the optic tract, contains the majority
Fig. 5. The colliculogeniculate projection is normal in b2/ mice. (A) and (B) Examples of [3H] proline tracing of the colliculogeniculate projection
in 2 b2/ mice. Dark ﬁeld photomicrographs of coronal sections show that large injections into the SC (A1, B1) lead to anterograde label in the
dLGN (A2, B2) that is concentrated dorsolaterally, adjacent to the optic tract. The number within each dLGN photomicrograph represents the
distance from the rostral pole of the dLGN, expressed as a percentage of the rostrocaudal extent of the nucleus. Numbers beneath each dLGN
photomicrograph show the %label_shell and relative density values (see Section 2) calculated for that section. SC, superior colliculus; LP, lateral
posterior nucleus; vLGN, ventral geniculate nucleus; rd, relative density; scalebars, 500 lm. (C) and (D) Quantitative comparison of the
colliculogeniculate projection in wild-type and b2/ mice. As expected from the dorsolateral concentration of anterograde label in the b2/
dLGN, the two groups do not diﬀer signiﬁcantly with respect to either %label_shell (C; wild-type mean ± SEM: 41 ± 2%; b2/: 43 ± 3%; t-test,
p = 0.64) or relative density (D; wild-type mean ± SEM: 1.37 ± 0.05; b2/: 1.55 ± 0.15; t-test with Welch correction, p = 0.3). Inset bar plots show
mean + SEM. WT, wild-type.
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ceives the greatest density of colliculogeniculate inputs.
In b2/ mice, the dLGN is known to possess abnor-
mal ocular lamination and other organisational anom-
alies; nevertheless, we show that biochemical and
colliculogeniculate subdivision of the nucleus is normal.
4.1. Biochemical and anatomical subdivision of the wild-
type mouse dLGN—comparison with other species
In all mammalian species studied thus far, the collicu-
logeniculate projection subdivides the dLGN, preferen-
tially targeting regions of the nucleus that contain the
smallest neurons (Harting et al., 1991; Reese, 1984,
1988). Indeed, Harting et al. (1991) suggest that the dis-
tribution of tectogeniculate axons is a straightforward and
simple way of identifying regions of the mammalian lat-
eral geniculate nucleus (p303). This is certainly the case
in the pigmented mouse. As shown here, colliculogenicu-
late aﬀerents preferentially target dorsolateral regions of
the wild-type mouse dLGN, adjacent to the optic tract.
In this localisation, and in its topographic precision, thisprojection is extremely similar to that previously de-
scribed in rats (Reese, 1984). It also closely resembles
the colliculogeniculate projection pattern observed in a
number of other rodent species (Harting et al., 1991).
Preferential targeting of the mouse dLGNs dorsolateral
shell by the colliculogeniculate projection also suggests
that this subregion might share homology with similar
tectorecipient regions in the carnivore and primate
dLGN. In monkeys and galagos, the SC targets almost
exclusively the koniocellular division of the dLGN,
whilst in carnivores it projects predominantly to the
dLGNs C laminae (Harting et al., 1991).
In its concentration of cells positive for the calcium-
binding protein calbindin D-28k, the dorsolateral shell
of the mouse dLGN further resembles the koniocellular
dLGN of the primate. Like the koniocellular laminae in
monkeys (Goodchild & Martin, 1998; Jones & Hendry,
1989) and galagos (Diamond et al., 1993; Johnson &
Casagrande, 1995), the mouse dLGNs dorsolateral
shell contains the majority, but not quite all, of the
calbindin-containing cells in the dLGN. This pattern
represents the ﬁrst description of the distribution of
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suggestive evidence from a low-resolution view of the rat
dLGN (Celio, 1990) hints that similar biochemical subdi-
vision might also occur in other rodent species. Whether
mouse calbindin-containing cells resemble their primate
counterparts in being glutamatergic relay neurons is,
though, a question open to further investigation.
The relation between neuronal biochemistry in the
dLGN and inter-species homology is complex. At one
level, the mouse and primate diﬀer from the cat in that,
in the latter, calbindin-containing neurons are found in
both tectorecipient C and non-tectorecipient A laminae
(Demeulemeester et al., 1991). These feline cells are also
unlike primate calbindin-positive cells in that they often
co-express GABA and parvalbumin (Demeulemeester
et al., 1991). Maybe one should expect closer biochemi-
cal homology between the mouse and primate dLGN
than between either and the carnivore dLGN, given
the far closer genetic relationship between rodents and
primates compared to either with carnivores (Arnason
et al., 2002). However, this argument might not quite
hold. The ﬂying fox, proposed (though this is still de-
bated; Ichida, Rosa, & Casagrande, 2000) to be a close
relative of the primates, displays a highly unusual pat-
tern of calbindin-positive cells in its dLGN: Neurons
containing calbindin are found profusely throughout
all layers of the nucleus (Ichida et al., 2000). Closely re-
lated species, then, might not necessarily display similar
patterns of calcium-binding protein expression in the
dLGN. In addition, the mouse dLGN is radically diﬀer-
ent from the primate dLGN in containing absolutely no
parvalbumin-positive cells. In monkeys (Goodchild &
Martin, 1998; Jones & Hendry, 1989) and galagos (Dia-
mond et al., 1993; Johnson & Casagrande, 1995), parv-
albumin is located in all non-koniocellular layers of the
dLGN. In cats parvalbumin-containing cells are com-
mon in all dLGN laminae (Demeulemeester et al.,
1991). Thus, while the projection from the SC and the
location of calbindin-containing cells make the dorsolat-
eral shell of the wild-type mouse dLGN similar to the
koniocellular laminae of monkeys and galagos, the lack
of parvalbumin-containing cells in the rest of the mouse
dLGN renders any homology with its primate non-
koniocellular counterpart partial at best.
4.2. Functional subdivision of the wild-type mouse dLGN?
As well as being anatomically and biochemically dif-
ferentiated from the remainder of the wild-type mouse
dLGN, is the dorsolateral shell region also functionally
distinct? The results of a previous study of visual re-
sponse properties in the wild-type mouse suggest not:
Geniculate cells located in the dorsolateral region of
the dLGN did not diﬀer in any functional respect from
cells situated in the remainder of the nucleus (Grubb &
Thompson, 2003). It would be very surprising, though,if the biochemical and anatomical diﬀerences discovered
within the wild-type mouse dLGN were not mirrored by
any diﬀerences in function. After all, in almost every re-
gion of every other mammalian visual system studied
thus far, structural diﬀerences are reﬂected in functional
diﬀerentiation. It is more likely, perhaps, that the dorso-
lateral shell of the mouse dLGN contains some neurons
that are functionally diﬀerent from the rest of the neu-
rons in that subregion, and from the remainder of cells
in the dLGN as a whole. These neurons could well have
been missed in the previous study (Grubb & Thompson,
2003). If they are similar to neurons in the tectorecipient
zones of the primate (e.g., Norton & Casagrande, 1982;
Xu et al., 2001) and cat (Sur & Sherman, 1982) dLGN,
functionally distinct cells in the mouse dLGNs dorsolat-
eral shell will be small, and will respond weakly and
sluggishly to visual stimulation. These cells action pot-
entials might therefore be biased against by the tungsten
recording electrodes employed in the previous study
(Grubb & Thompson, 2003; So & Shapley, 1979), while
their visual responses might have been overlooked in fa-
vour of more reliably and briskly ﬁring neurons. Indeed,
these are presumably some of the reasons why the pri-
mate koniocellular pathway was overlooked for so long
(Casagrande, 1994). Perhaps future investigations
employing more systematic sampling techniques, stimu-
lation of the SC, and/or intracellular recording followed
by cell ﬁlling and immunocytochemical staining, will un-
cover a distinct functional subpopulation of mouse
dLGN neurons that has so far been overlooked.4.3. Normal biochemical and anatomical subdivision of
the b2/ dLGN
Despite the disruption of ocular lamination (Muir-
Robinson et al., 2002; Rossi et al., 2001) and other as-
pects of organisation (Grubb et al., 2003) in the b2/
dLGN, the subdivision of the nucleus by collicular
aﬀerents and calbindin-positive neurons is entirely nor-
mal. The formation of eye-speciﬁc regions (Muir-Robin-
son et al., 2002; Rossi et al., 2001), ﬁne retinotopy (Grubb
et al., 2003), and On–Oﬀ cell arrangements (Grubb et al.,
2003) in the dLGN can therefore be completely
independent of the formation of other biochemical and
anatomical geniculate subdivisions. Our data also dem-
onstrate that normal biochemical and colliculogeniculate
subdivision of the dLGN is entirely independent of trans-
mission through b2-subunit-containing nAChRs any-
where in the brain and at any point in development.
Furthermore, since the developmental eﬀects of the
b2/ mutation on geniculate organisation are believed
to stem from abnormalities in the patterning of spontane-
ous activity in the early postnatal retina (McLaughlin
et al., 2003), our data show that subdivision of the dLGN
by collicular aﬀerents and calbindin-containing neurons
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natal retinal ganglion cells.
These results might have been predicted by develop-
mental studies in the cat. Subdivision of the cat dLGN
by the colliculogeniculate projection depends on an intact
retinal projection (Sutton & Brunso-Bechtold, 1988), but
occurs extremely late in postnatal development, at a time
when eye-speciﬁc laminae have already formed (Stein,
McHaﬃe, Harting, Huerta, & Hashikawa, 1985). Since
the retinal eﬀects of the b2/ mutation occur primarily
in early postnatal life (Bansal et al., 2000; McLaughlin
et al., 2003; Muir-Robinson et al., 2002), it might not,
therefore, be too surprising that the colliculogeniculate
projection is normal in b2/mice. Nevertheless, it is still
striking that this projection can target appropriate regions
of the dLGN even when other organisational features of
the nucleus have already been profoundly disrupted.
Finally, the reduced number of calbindin-positive
cells in the b2/ dLGN is striking: WT mice have
approximately seven times as many calbindin-positive
cells as b2/ mice. Although we have not measured
neuronal density in WT and b2/ dLGN, it seems very
unlikely that the reduction is explained simply by a
change in neuronal density in the b2/ LGN. Because
of their low incidence even in the WT dLGN, neuronal
density measures are also unlikely to reveal whether
there is a loss of calbindin staining or a loss of neurons
that express calbindin. The mechanism for the selective
loss of calbindin labelling can only be guessed at. It
could be a consequence of perturbed retinal activity,
or it could arise from altered thalamic cholinergic mod-
ulation. We note one important implication of this re-
sult, however: Although calbindin-containing cells and
the colliculogeniculate projection are always most con-
centrated in the dorsolateral shell of the mouse dLGN,
the fact that calbindin-positive cells can be drastically re-
duced in number without aﬀecting the localisation of
colliculogeniculate aﬀerents suggests these two genicu-
late-subdividing features are not totally interdependent.Acknowledgments
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